Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scopolamine reduces frontal cortex perfusion.

W G Honer1, I Prohovnik, G Smith

  • 1Department of Psychiatry, College of Physicians and Surgeons, Columbia University.

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|October 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative evaluation of a chemiluminescent DNA probe and an exoantigen test for rapid identification of Histoplasma capsulatum.

Journal of clinical microbiology·1992
Same author

Modeling the power of the aging human eye.

Journal of the Optical Society of America. A, Optics and image science·1992
Same author

Colposcopic and histologic findings and human papillomavirus (HPV) DNA test variability in young women positive for HPV DNA.

The Journal of infectious diseases·1992
Same author

Hip pain caused by buttock claudication. Relief of symptoms by transluminal angioplasty.

Clinical orthopaedics and related research·1992
Same author

Common genetic pathways in breast oncogenesis.

Pathologie-biologie·1992
Same author

Molecular genetics of the human cytochrome P450-dependent monooxygenases.

The Tohoku journal of experimental medicine·1992

Cholinergic blockade impairs cognition and alters cerebral blood flow (CBF). Scopolamine caused frontal CBF reduction, unlike Alzheimer's disease patterns, suggesting frontal deficits in dementia may involve cholinergic dysfunction.

Area of Science:

  • Neuroscience
  • Neurology
  • Pharmacology

Background:

  • Alzheimer's disease (AD) cognitive deficits are linked to cholinergic system impairment.
  • The characteristic regional cerebral blood flow (rCBF) pattern in AD has not been directly linked to cholinergic deficits.

Purpose of the Study:

  • To investigate if the regional cerebral blood flow (rCBF) pattern in Alzheimer's disease is related to cholinergic deficits.
  • To test the hypothesis that cholinergic blockade induces an rCBF pattern similar to that observed in Alzheimer's disease.

Main Methods:

  • Measured rCBF using the 133Xe inhalation technique in 15 young healthy subjects.
  • Administered intravenous scopolamine at doses of 6.1 and 7.3 micrograms/kg to induce reversible cholinergic blockade.
  • Assessed cognitive function and rCBF changes before and after scopolamine administration.

Related Experiment Videos

Main Results:

  • Significant cognitive impairment occurred at both scopolamine doses.
  • rCBF changes were observed only at the higher dose (7.3 micrograms/kg).
  • Global CBF significantly decreased 25 minutes post-scopolamine.
  • The observed rCBF pattern showed a predominant frontal reduction (~20%), differing from the parietotemporal deficits typical of Alzheimer's disease.

Conclusions:

  • Cholinergic dysfunction, induced by scopolamine, leads to cognitive impairment and altered cerebral blood flow.
  • The study suggests that frontal deficits observed in some dementing conditions may be associated with cholinergic dysfunction.
  • The rCBF pattern induced by cholinergic blockade does not mimic the characteristic parietotemporal deficits seen in Alzheimer's disease.